Mintz represented Delta Associated Investigations, a tech-enabled national provider of investigative and claims support ...

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies ...

Mintz represented the US Department of Energy in the closing of two separate loans totaling up to approximately $5.1 billion ...

The Inflation Reduction Act (IRA) continues to reshape the US drug‑pricing landscape as federal implementation accelerates and market responses evolve. In 2025, regulators advanced core IRA programs ...

Mitch Frazer, Managing Partner of Mintz's Toronto office, has received an honorary Doctor of Laws degree from Western ...

On June 30, 2025, New Jersey enacted legislation that now incorporates the US federal qualified small business stock (QSBS) rules under Section[1] 1202, effective for dispositions of QSBS for tax ...

Benchmark Litigation has recognized 23 Mintz attorneys in its 2027 guide to the leading litigation firms and lawyers in the United States. Mintz was also named Highly Recommended in Massachusetts and ...

Michael Renaud, Chair of Mintz’s Intellectual Property Division, has been named to IAM Global Leaders 2027, a guide ...

Mintz’s Managed Care, PBMs & Pharmacies practice is pleased to present a combined Summer / Fall 2025 PBM Policy and Legislative Update. This edition builds upon prior issues and summarizes activity ...

Alex regularly represents issuers, underwriters, sponsors, investors, and investment banks in cross-border financings and ...

On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a request for information (RFI) titled “Pharmacy Benefit Manager Compensation and Data Collection,” seeking industry input ...